Recruiting NA INTERVENTIONAL 2-arm NCT05116904

Smith Magenis Syndrome and Autism Spectrum Disorders (SMS/TSA)

Chronobiological Characterization of Smith Magenis Syndrome and Autism Spectrum Disorders in Paediatric Age

Sponsor: Hospices Civils de Lyon

Conditions Autism Spectrum Disorder Smith-Magenis Syndrome

Interventions Assessment

Updated 4 times since 2021 Last updated: Jun 4, 2024 Started: Mar 30, 2022 Primary completion: Apr 30, 2026 Completion: Apr 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05116904, this NA trial focuses on Autism Spectrum Disorder and Smith-Magenis Syndrome and remains actively recruiting participants. Sponsored by Hospices Civils de Lyon, it has been updated 4 times since 2022, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Nov 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2021 — Nov 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bron, France